Krystal Biotech, Inc. (KRYS) /

The profitability of Krystal Biotech, Inc. over the past 10 years

Chart Krystal Biotech, Inc.: operating income, net income, fiscal 2016–2025 Open the chart →

Krystal Biotech, Inc. reported net income of $204.83M in fiscal 2025, the latest fiscal year on file. That year it had operating income of $161.29M. It reported a profit in 3 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019, 2020, 2021 and 2022.

Year by year

Fiscal yearOperating incomeNet income
2025ended Dec 31, 2025$161.29M$204.83M
2024ended Dec 31, 2024$65.75M$89.16M
2023ended Dec 31, 2023-$109.62M$10.93M
2022ended Dec 31, 2022-$145.2M-$139.97M
2021ended Dec 31, 2021-$68.28M-$69.57M
2020ended Dec 31, 2020-$33M-$32.17M
2019ended Dec 31, 2019-$22.08M-$19.09M
2018ended Dec 31, 2018-$11.92M-$10.89M
2017ended Dec 31, 2017-$4.77M-$7.92M
2016ended Dec 31, 2016-$1.14M-$1.15M

Fiscal years as Krystal Biotech, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on Krystal Biotech, Inc.

Companies of a similar size

Not investment advice. This page shows what Krystal Biotech, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.